Home/Filings/4/0001415889-25-022523
4//SEC Filing

Busque Philippe 4

Accession 0001415889-25-022523

CIK 0001831915other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 5:56 PM ET

Size

20.6 KB

Accession

0001415889-25-022523

Insider Transaction Report

Form 4
Period: 2025-08-18
Busque Philippe
SVP, GLOBAL SALES AND SERVICES
Transactions
  • Tax Payment

    Common Stock

    2025-08-18$4.06/sh861$3,49621,203 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-183,62551,963 total
    Common Stock (3,625 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-18+2,21022,064 total
  • Exercise/Conversion

    Common Stock

    2025-08-18+1,53620,453 total
  • Tax Payment

    Common Stock

    2025-08-18$4.06/sh1,412$5,73323,416 total
  • Exercise/Conversion

    Common Stock

    2025-08-18+3,62524,828 total
  • Tax Payment

    Common Stock

    2025-08-18$4.06/sh599$2,43219,854 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-181,53610,250 total
    Common Stock (1,536 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-08-182,21022,838 total
    Common Stock (2,210 underlying)
Footnotes (5)
  • [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
  • [F3]The shares subject to the RSU Award shall vest over four years with 13/48 of the total shares underlying the RSU Award vesting on May 18, 2024; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter; and 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter.
  • [F4]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter.
  • [F5]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested.

Issuer

Cytek Biosciences, Inc.

CIK 0001831915

Entity typeother

Related Parties

1
  • filerCIK 0001991396

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:56 PM ET
Size
20.6 KB